Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Follicular thyroid carcinoma (FTC) has different clinicopathological characteristics than papillary thyroid carcinoma. However, there are no independent systems to predict cancer-specific survival (CSS) in FTC. Telomerase reverse transcriptase (
TERT
) promoter mutations are associated with tumor aggressiveness. Thus, it could be a potential...
Alternative Titles
Full title
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8786663
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8786663
Other Identifiers
ISSN
0893-3952
E-ISSN
1530-0285
DOI
10.1038/s41379-021-00907-6
